These findings are supported by mechanistic studies into the structure of the T cell receptor (TCR) from an MS patient, which recognized both a DRB1*1501-restricted myelin basic protein (MBP) peptide and a DRB5*0101-restricted EBV peptide. This evidence concerns the gene MBP and myeloid sarcoma.